Table II.
Study | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias |
---|---|---|---|---|---|---|---|
Cepeda et al (25) | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
Koch et al (23) | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
Yilmaz et al (26) | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | High risk |
Marsdin et al (22) | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
Akbas et al (27) | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Low risk |
Karalar et al (28) | High risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
Cakmak et al (29) | Unclear risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Low risk |
Jurado et al (30) | Low risk | Unclear risk | High risk | Low risk | Low risk | Unclear risk | Unclear risk |
Gezginci et al (31) | Low risk | Unclear risk | High risk | High risk | Low risk | Low risk | Low risk |
El-Khoury et al (32) | Low risk | Unclear risk | High risk | High risk | Low risk | Unclear risk | Unclear risk |
Çift et al (24) | Low risk | Low risk | High risk | Low risk | Low risk | Unclear risk | Low risk |